Upstream Bio, Inc. · NASDAQ:UPB

Deykin Aaron sold 895 Upstream Bio, Inc. shares (Form 4)

Traded Jun 16, 2026 · Filed Jun 17, 2026

On Jun 16, 2026, Deykin Aaron (Chief Medical Officer) sold 895 Upstream Bio, Inc. shares at US$6.10 for US$5,460, leaving 33,197 shares. Filed Jun 17, 2026 (Form 4).

Sold
895 shares
Price
US$6.10
Value
US$5,460
Holding after
33,197 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 16, 2026Common StockSale895US$6.1033,197Direct

Source

View original at SEC

Related